A Phase 1, Open-Label, Drug-Drug Interaction Study Between Methadone and Daclatasvir/Asunaprevir/BMS-791325 3 DAA FDC + 75mg BMS-791325 and Between Buprenorphine/Naloxone and Daclatasvir/Asunaprevir/BMS-791325 3 DAA FDC +75mg BMS-791325
Latest Information Update: 11 Aug 2015
At a glance
- Drugs Asunaprevir/becabluvir/daclatasvir (Primary) ; Beclabuvir; Buprenorphine/naloxone; Methadone
- Indications Hepatitis C
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 12 Jun 2014 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov record.
- 03 Feb 2014 New trial record